initial public offerings (IPOs) trading on American exchanges
Showing posts with label AIRS. Show all posts
Showing posts with label AIRS. Show all posts

Friday, May 2, 2025

AirSculpt Technologies (AIRS) reported earnings on Fri 2 May 25 (b/o)

AirSculpt Technologies provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.
  • Sector: Healthcare
  • Industry: Medical Care Facilities
  • Full Time Employees: 389
  • Founded by Aaron J. Rollins in 2012  
  • Headquartered in Miami Beach, Florida
  • https://airsculpt.com
Ticker: AIRS
** charts after earnings **





 

First Quarter 2025 Results
  • Case volume was 3,076 for the first quarter of 2025, representing a 17.9% decline from the fiscal year 2024 first quarter case volume of 3,746;
  • Revenue declined 17.3% to $39.4 million from $47.6 million in the fiscal year 2024 first quarter;
  • Net loss for the quarter was $2.8 million compared to net income of $6.0 million in the fiscal year 2024 first quarter; and Adjusted EBITDA was $3.8 million compared to $7.3 million for the fiscal year 2024 first quarter.
2025 Outlook
The Company projects full year 2025 revenue and adjusted EBITDA guidance as follows:
  • Revenues of approximately $160 to $170 million
  • Adjusted EBITDA of approximately $16 to $18 million

Monday, November 22, 2021

IPOs this week : Nov. 22 - 26, 21 (wk 47)

IPO quiet period expirations
  • Globalfoundries (NASDAQ:GFS), Fluence Energy (NASDAQ:FLNC), Informatica (NYSE:INFA), Rent the Runway (NASDAQ:RENT), Solo Brands (NYSE:DTC), Arteris (NASDAQ:AIP), Augmedix (NASDAQ:AUGX) and Marpai (NASDAQ:MRAI) on November 22. 
  • HireRight (NYSE:HRT), Udemy (NASDAQ:UDMY), Entrada Therapeutics (NASDAQ:TRDA), Sonendo (NYSE:SONX), AirSculpt Technologies (NASDAQ:AIRS), Aura Biosciences (NASDAQ:AURA), Biofrontera (NASDAQ:BFRI) on November 23.
IPO lockup expirations
  • Paymentus (PAY) on November 22, 
  • Figs (NYSE:FIGS), Singular Genomics Systems (NASDAQ:OMIC) and Day One Biopharmaceuticals (NASDAQ:DAWN) on November 23. 
  • Centessa Pharmaceuticals (NASDAQ:CNTA) and Zivo Bioscience (NASDAQ:ZIVO) see IPO lockup periods end on November 24 and LianBio (NASDAQ:LIAN) has its lockup period expiring on November 26.